메뉴 건너뛰기




Volumn 10, Issue 5, 2013, Pages 261-273

Management of cardiovascular disease in patients with kidney disease

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; APIXABAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; DABIGATRAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; LOSARTAN; PLACEBO; RIVAROXABAN; VALSARTAN; WARFARIN;

EID: 84876897043     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2013.15     Document Type: Review
Times cited : (94)

References (155)
  • 1
    • 84934273067 scopus 로고    scopus 로고
    • Atlas of CKD & ESRD [online] 2012
    • US Renal Data System. 2011 Atlas of CKD & ESRD [online], http://www.usrds.org/atlas11.aspx (2012).
    • (2011) US Renal Data System.
  • 2
    • 0034922894 scopus 로고    scopus 로고
    • Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: A cross-sectional study
    • Stack, A. G. & Bloembergen, W. E. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: A cross-sectional study. J. Am. Soc. Nephrol. 12, 1516-1523 (2001).
    • (2001) J. Am. Soc. Nephrol. , vol.12 , pp. 1516-1523
    • Stack, A.G.1    Bloembergen, W.E.2
  • 3
    • 0032541672 scopus 로고    scopus 로고
    • Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
    • Herzog, C. A., Ma, J. Z. & Collins, A. J. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N. Engl. J. Med. 339, 799-805 (1998).
    • (1998) N. Engl. J. Med. , vol.339 , pp. 799-805
    • Herzog, C.A.1    Ma, J.Z.2    Collins, A.J.3
  • 4
    • 0030995276 scopus 로고    scopus 로고
    • Onset of coronary artery disease prior to initiation of hemodialysis in patients with end-stage renal disease
    • Joki, N., Hase, H., Nakamura, R. & Yamaguchi, T. Onset of coronary artery disease prior to initiation of hemodialysis in patients with end-stage renal disease. Nephrol. Dial. Transplant. 12, 718-723 (1997).
    • (1997) Nephrol. Dial. Transplant. , vol.12 , pp. 718-723
    • Joki, N.1    Hase, H.2    Nakamura, R.3    Yamaguchi, T.4
  • 5
    • 24344477577 scopus 로고    scopus 로고
    • High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination
    • Ohtake, T. et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J. Am. Soc. Nephrol. 16, 1141-1148 (2005).
    • (2005) J. Am. Soc. Nephrol. , vol.16 , pp. 1141-1148
    • Ohtake, T.1
  • 6
    • 33847281906 scopus 로고    scopus 로고
    • Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients
    • Charytan, D., Kuntz, R. E., Mauri, L. & DeFilippi, C. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am. J. Kidney Dis. 49, 409-416 (2007).
    • (2007) Am. J. Kidney Dis. , vol.49 , pp. 409-416
    • Charytan, D.1    Kuntz, R.E.2    Mauri, L.3    DeFilippi, C.4
  • 7
    • 0036719916 scopus 로고    scopus 로고
    • Inflammation in end-stage renal disease: Sources, consequences, and therapy
    • Stenvinkel, P. & Alvestrand, A. Inflammation in end-stage renal disease: Sources, consequences, and therapy. Semin. Dial. 15, 329-337 (2002).
    • (2002) Semin. Dial. , vol.15 , pp. 329-337
    • Stenvinkel, P.1    Alvestrand, A.2
  • 8
    • 0027301576 scopus 로고
    • Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup
    • Manske, C. L., Thomas, W., Wang, T. & Wilson, R. F. Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int. 44, 617-621 (1993).
    • (1993) Kidney Int. , vol.44 , pp. 617-621
    • Manske, C.L.1    Thomas, W.2    Wang, T.3    Wilson, R.F.4
  • 9
    • 0036055582 scopus 로고    scopus 로고
    • C reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients
    • Wanner, C. & Metzger, T. C reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol. Dial. Transplant. 17, 29-32 (2002).
    • (2002) Nephrol. Dial. Transplant. , vol.17 , pp. 29-32
    • Wanner, C.1    Metzger, T.2
  • 10
    • 0036435820 scopus 로고    scopus 로고
    • Cardiovascular calcification in patients with end-stage renal disease: A
    • century-old phenomenon
    • Qunibi, W. Y., Nolan, C. A. & Ayus, J. C. Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon. Kidney Int. Suppl. 82, S73- S80 (2002).
    • (2002) Kidney Int. Suppl. , vol.82
    • Qunibi, W.Y.1    Nolan, C.A.2    Ayus, J.C.3
  • 11
    • 0031920748 scopus 로고    scopus 로고
    • Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
    • Block, G. A., Hulbert-Shearon, T. E., Levin, N. W. & Port, F. K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am. J. Kidney Dis. 31, 607-617 (1998).
    • (1998) Am. J. Kidney Dis. , vol.31 , pp. 607-617
    • Block, G.A.1    Hulbert-Shearon, T.E.2    Levin, N.W.3    Port, F.K.4
  • 12
    • 39049096394 scopus 로고    scopus 로고
    • Mechanisms of vascular calcification in chronic kidney disease
    • Moe, S. M. & Chen, N. X. Mechanisms of vascular calcification in chronic kidney disease. J. Am. Soc. Nephrol. 19, 213-216 (2008).
    • (2008) J. Am. Soc. Nephrol. , vol.19 , pp. 213-216
    • Moe, S.M.1    Chen, N.X.2
  • 14
    • 0037181496 scopus 로고    scopus 로고
    • Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis
    • Klassen, P. S. et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287, 1548-1555 (2002).
    • (2002) JAMA , vol.287 , pp. 1548-1555
    • Klassen, P.S.1
  • 15
    • 82455171881 scopus 로고    scopus 로고
    • Coronary artery disease in a large renal transplant population: Implications for management
    • Kahn, M. R., Fallahi, A., Kim, M. C., Esquitin, R. & Robbins, M. J. Coronary artery disease in a large renal transplant population: implications for management. Am. J. Transplant. 11, 2665-2674 (2011).
    • (2011) Am. J. Transplant. , vol.11 , pp. 2665-2674
    • Kahn, M.R.1    Fallahi, A.2    Kim, M.C.3    Esquitin, R.4    Robbins, M.J.5
  • 16
    • 0038645354 scopus 로고    scopus 로고
    • Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation
    • Patel, A. D. et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am. J. Cardiol. 92, 146-151 (2003).
    • (2003) Am. J. Cardiol. , vol.92 , pp. 146-151
    • Patel, A.D.1
  • 17
    • 0042835365 scopus 로고    scopus 로고
    • Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing
    • De Lima, J. J. et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 42, 263-268 (2003).
    • (2003) Hypertension , vol.42 , pp. 263-268
    • De Lima, J.J.1
  • 18
    • 84878530092 scopus 로고    scopus 로고
    • Cardiac testing for coronary artery disease in potential kidney transplant recipients
    • 1 Art No CD008691
    • Wang, L. W. et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Systematic Reviews, Issue 1 Art. No.: CD008691 http://dx.doi.org/10.1002/14651858.CD008691.pub2 (2011).
    • (2011) Cochrane Database Systematic Reviews
    • Wang, L.W.1
  • 19
    • 84864475111 scopus 로고    scopus 로고
    • Cardiac disease evaluation and management among kidney and liver transplantation candidates: A scientific statement from the american heart association and the american college of cardiology foundation
    • Lentine, K. L. et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 126, 617-663 (2012).
    • (2012) Circulation , vol.126 , pp. 617-663
    • Lentine, K.L.1
  • 20
    • 23844465424 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients
    • K/DOQI Workgroup
    • K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am. J. Kidney Dis. 45 (Suppl. 3), S1- S153 (2005).
    • (2005) Am. J. Kidney Dis. , vol.45 , Issue.SUPPL. 3
  • 21
    • 79957847642 scopus 로고    scopus 로고
    • A call to action: Variability in guidelines for cardiac evaluation before renal transplantation
    • Friedman, S. E. et al. A call to action: variability in guidelines for cardiac evaluation before renal transplantation. Clin. J. Am. Soc. Nephrol. 6, 1185-1191 (2011).
    • (2011) Clin. J. Am. Soc. Nephrol. , vol.6 , pp. 1185-1191
    • Friedman, S.E.1
  • 22
    • 83155173970 scopus 로고    scopus 로고
    • 2011 accf/aha guideline for coronary artery bypass graft surgery: A report of the american college of cardiology foundation/american heart association task force on practice guidelines
    • Hillis, L. D. et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124, e652- e735 (2011).
    • (2011) Circulation , vol.124
    • Hillis, L.D.1
  • 23
    • 84858330788 scopus 로고    scopus 로고
    • Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: A systematic review and meta-analysis
    • Palmer, S. C. et al. Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: A systematic review and meta-analysis. Ann. Intern. Med. 156, 445-459 (2012).
    • (2012) Ann. Intern. Med. , vol.156 , pp. 445-459
    • Palmer, S.C.1
  • 24
    • 38749104314 scopus 로고    scopus 로고
    • Major bleeding in hemodialysis patients
    • Holden, R. M. et al. Major bleeding in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 3, 105-110 (2008).
    • (2008) Clin. J. Am. Soc. Nephrol. , vol.3 , pp. 105-110
    • Holden, R.M.1
  • 25
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • Hansson, L. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351, 1755-1762 (1998).
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1
  • 26
    • 77956525281 scopus 로고    scopus 로고
    • Aspirin is beneficial in hypertensive patients with chronic kidney disease: A post-hoc subgroup analysis of a randomized controlled trial
    • Jardine, M. J. et al. Aspirin is beneficial in hypertensive patients with chronic kidney disease: A post-hoc subgroup analysis of a randomized controlled trial. J. Am. Coll. Cardiol. 56, 956-965 (2010).
    • (2010) J. Am. Coll. Cardiol. , vol.56 , pp. 956-965
    • Jardine, M.J.1
  • 27
    • 79953296443 scopus 로고    scopus 로고
    • Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention
    • Htun, P. et al. Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention. J. Am. Soc. Nephrol. 22, 627-633 (2011).
    • (2011) J. Am. Soc. Nephrol. , vol.22 , pp. 627-633
    • Htun, P.1
  • 28
    • 78751605846 scopus 로고    scopus 로고
    • Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel
    • Morel, O. et al. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. J. Am. Coll. Cardiol. 57, 399-408 (2011).
    • (2011) J. Am. Coll. Cardiol. , vol.57 , pp. 399-408
    • Morel, O.1
  • 29
    • 78149357797 scopus 로고    scopus 로고
    • Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after acute coronary syndrome
    • Cuisset, T. et al. Lack of effect of chronic kidney disease on clopidogrel response with high loading and maintenance doses of clopidogrel after acute coronary syndrome. Thromb. Res. 126, e400- e402 (2010).
    • (2010) Thromb. Res. , vol.126
    • Cuisset, T.1
  • 30
    • 77649207350 scopus 로고    scopus 로고
    • Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy
    • Angiolillo, D. J. et al. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J. Am. Coll. Cardiol. 55, 1139-1146 (2010).
    • (2010) J. Am. Coll. Cardiol. , vol.55 , pp. 1139-1146
    • Angiolillo, D.J.1
  • 31
    • 0037145863 scopus 로고    scopus 로고
    • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
    • Clopidogrel for the Reduction of Events During Observation.
    • Steinhubl, S. R. et al. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 288, 2411-2420 (2002).
    • (2002) JAMA , vol.288 , pp. 2411-2420
    • Steinhubl, S.R.1
  • 32
    • 40849083770 scopus 로고    scopus 로고
    • The efficacy and safety of short-and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial
    • Best, P. J. et al. The efficacy and safety of short-and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am. Heart J. 155, 687-693 (2008).
    • (2008) Am. Heart J. , vol.155 , pp. 687-693
    • Best, P.J.1
  • 33
    • 70149101223 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in patients with acute coronary syndromes
    • Wallentin, L. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 361, 1045-1057 (2009).
    • (2009) N. Engl. J. Med. , vol.361 , pp. 1045-1057
    • Wallentin, L.1
  • 34
    • 77957270303 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: Results from the Platelet Inhibition and Patient Outcomes (PLATO) trial
    • James, S. et al. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: Results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation 122, 1056-1067 (2010).
    • (2010) Circulation , vol.122 , pp. 1056-1067
    • James, S.1
  • 35
    • 36148983750 scopus 로고    scopus 로고
    • Prasugrel versus clopidogrel in patients with acute coronary syndromes
    • Wiviott, S. D. et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 357, 2001-2015 (2007).
    • (2007) N. Engl. J. Med. , vol.357 , pp. 2001-2015
    • Wiviott, S.D.1
  • 36
    • 68649098919 scopus 로고    scopus 로고
    • Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease
    • Small, D. S. et al. Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease. J. Clin. Pharm. Ther. 34, 585-594 (2009).
    • (2009) J. Clin. Pharm. Ther. , vol.34 , pp. 585-594
    • Small, D.S.1
  • 37
    • 1442316135 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease
    • Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
    • Kidney Disease Outcomes Quality Initiative (K/DOQI) Group. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am. J. Kidney Dis. 41 (Suppl. 3), S1- S91 (2003).
    • (2003) Am. J. Kidney Dis. , vol.41 , Issue.SUPPL. 3
  • 38
    • 84865602423 scopus 로고    scopus 로고
    • Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study
    • Tonelli, M. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study. Lancet 380, 807-814 (2012).
    • (2012) Lancet , vol.380 , pp. 807-814
    • Tonelli, M.1
  • 39
    • 0037126526 scopus 로고    scopus 로고
    • Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults Adult Treatment Panel III): Final report
    • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation 106, 3143-3421 (2002).
    • (2002) Circulation , vol.106 , pp. 3143-3421
  • 40
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group.
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360, 7-22 (2002).
    • (2002) Lancet , vol.360 , pp. 7-22
  • 41
    • 0037458229 scopus 로고    scopus 로고
    • Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency
    • Tonelli, M. et al. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann. Intern. Med. 138, 98-104 (2003).
    • (2003) Ann. Intern. Med. , vol.138 , pp. 98-104
    • Tonelli, M.1
  • 42
    • 20844462717 scopus 로고    scopus 로고
    • Effect of pravastatin on cardiovascular events in people with chronic kidney disease
    • Tonelli, M. et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 110, 1557-1563 (2004).
    • (2004) Circulation , vol.110 , pp. 1557-1563
    • Tonelli, M.1
  • 43
    • 41549159287 scopus 로고    scopus 로고
    • Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: The TNT (Treating to New Targets) study
    • Shepherd, J. et al. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: The TNT (Treating to New Targets) study. J. Am. Coll. Cardiol. 51, 1448-1454 (2008).
    • (2008) J. Am. Coll. Cardiol. , vol.51 , pp. 1448-1454
    • Shepherd, J.1
  • 44
    • 22344458137 scopus 로고    scopus 로고
    • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
    • Wanner, C. et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N. Engl. J. Med. 353, 238-248 (2005).
    • (2005) N. Engl. J. Med. , vol.353 , pp. 238-248
    • Wanner, C.1
  • 45
    • 63849163945 scopus 로고    scopus 로고
    • Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
    • Fellström, B. C. et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360, 1395-1407 (2009).
    • (2009) N. Engl. J. Med. , vol.360 , pp. 1395-1407
    • Fellström, B.C.1
  • 46
    • 79959746706 scopus 로고    scopus 로고
    • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial
    • Baigent, C. et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet 377, 2181-2192 (2011).
    • (2011) Lancet , vol.377 , pp. 2181-2192
    • Baigent, C.1
  • 47
    • 79959707564 scopus 로고    scopus 로고
    • SHARP: A stab in the right direction in chronic kidney disease
    • Stevens, K. K. & Jardine, A. G. SHARP: A stab in the right direction in chronic kidney disease. Lancet 377, 2153-2154 (2011).
    • (2011) Lancet , vol.377 , pp. 2153-2154
    • Stevens, K.K.1    Jardine, A.G.2
  • 48
    • 79960126385 scopus 로고    scopus 로고
    • Rosuvastatin in diabetic hemodialysis patients
    • Holdaas, H. et al. Rosuvastatin in diabetic hemodialysis patients. J. Am. Soc. Nephrol. 22, 1335-1341 (2011).
    • (2011) J. Am. Soc. Nephrol. , vol.22 , pp. 1335-1341
    • Holdaas, H.1
  • 49
    • 79959695664 scopus 로고    scopus 로고
    • Statins inflammation and kidney disease
    • Krane, V. & Wanner, C. Statins, inflammation and kidney disease. Nat. Rev. Nephrol. 7, 385-397 (2011).
    • (2011) Nat. Rev. Nephrol. , vol.7 , pp. 385-397
    • Krane, V.1    Wanner, C.2
  • 50
    • 0032784499 scopus 로고    scopus 로고
    • Serum C reactive protein (CRP) and risk of death in chronic dialysis patients
    • Iseki, K., Tozawa, M., Yoshi, S. & Fukiyama, K. Serum C reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol. Dial. Transplant. 14, 1956-1960 (1999).
    • (1999) Nephrol. Dial. Transplant. , vol.14 , pp. 1956-1960
    • Iseki, K.1    Tozawa, M.2    Yoshi, S.3    Fukiyama, K.4
  • 51
    • 56549092147 scopus 로고    scopus 로고
    • Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis
    • Krane, V. et al. Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis. Kidney Int. 74, 1461-1467 (2008).
    • (2008) Kidney Int. , vol.74 , pp. 1461-1467
    • Krane, V.1
  • 52
    • 0033800718 scopus 로고    scopus 로고
    • Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice
    • Laufs, U. et al. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31, 2442-2449 (2000).
    • (2000) Stroke , vol.31 , pp. 2442-2449
    • Laufs, U.1
  • 53
    • 0035936406 scopus 로고    scopus 로고
    • Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study
    • Zoccali, C. et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358, 2113-2117 (2001).
    • (2001) Lancet , vol.358 , pp. 2113-2117
    • Zoccali, C.1
  • 54
    • 28444435118 scopus 로고    scopus 로고
    • Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach
    • Ravani, P. et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach. J. Am. Soc. Nephrol. 16, 2449-2455 (2005).
    • (2005) J. Am. Soc. Nephrol. , vol.16 , pp. 2449-2455
    • Ravani, P.1
  • 55
    • 4944262612 scopus 로고    scopus 로고
    • Survival after coronary revascularization among patients with kidney disease
    • Hemmelgarn, B. R. et al. Survival after coronary revascularization among patients with kidney disease. Circulation 110, 1890-1895 (2004).
    • (2004) Circulation , vol.110 , pp. 1890-1895
    • Hemmelgarn, B.R.1
  • 56
    • 0034951268 scopus 로고    scopus 로고
    • Differential survival after coronary revascularization procedures among patients with renal insufficiency
    • Szczech, L. A. et al. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int. 60, 292-299 (2001).
    • (2001) Kidney Int. , vol.60 , pp. 292-299
    • Szczech, L.A.1
  • 57
    • 0037159275 scopus 로고    scopus 로고
    • Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes
    • Herzog, C. A., Ma, J. Z. & Collins, A. J. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106, 2207-2211 (2002).
    • (2002) Circulation , vol.106 , pp. 2207-2211
    • Herzog, C.A.1    Ma, J.Z.2    Collins, A.J.3
  • 58
    • 2942677259 scopus 로고    scopus 로고
    • Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures
    • Herzog, C. A., Ma, J. Z. & Collins, A. J. Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures. Circulation 109, 2866-2871 (2004).
    • (2004) Circulation , vol.109 , pp. 2866-2871
    • Herzog, C.A.1    Ma, J.Z.2    Collins, A.J.3
  • 59
    • 34548435117 scopus 로고    scopus 로고
    • Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation
    • Hage, F. G. et al. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am. J. Cardiol. 100, 1020-1025 (2007).
    • (2007) Am. J. Cardiol. , vol.100 , pp. 1020-1025
    • Hage, F.G.1
  • 60
    • 77952305530 scopus 로고    scopus 로고
    • Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis
    • Sunagawa, G. et al. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann. Thorac. Surg. 89, 1896-1900 (2010).
    • (2010) Ann. Thorac. Surg. , vol.89 , pp. 1896-1900
    • Sunagawa, G.1
  • 61
    • 67651162307 scopus 로고    scopus 로고
    • Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: Does a drug-eluting stent have an impact on clinical outcome?
    • Manabe, S. et al. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: Does a drug-eluting stent have an impact on clinical outcome? J. Card. Surg. 24, 234-239 (2009).
    • (2009) J Card. Surg. , vol.24 , pp. 234-239
    • Manabe, S.1
  • 62
    • 28844443938 scopus 로고    scopus 로고
    • Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS IV trial
    • Halkin, A. et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS IV trial. Am. Heart J. 150, 1163-1170 (2005).
    • (2005) Am. Heart J. , vol.150 , pp. 1163-1170
    • Halkin, A.1
  • 63
    • 0036135463 scopus 로고    scopus 로고
    • Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure
    • Gruberg, L. et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter. Cardiovasc. Interv. 55, 66-72 (2002).
    • (2002) Catheter. Cardiovasc. Interv. , vol.55 , pp. 66-72
    • Gruberg, L.1
  • 64
    • 79953693894 scopus 로고    scopus 로고
    • Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3 year clinical outcomes after sirolimus-eluting stent implantation: Insights from the Japan multi-centre post-marketing surveillance registry
    • Otsuka, Y. et al. Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3 year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registry. Eur. Heart J. 32, 829-837 (2011).
    • (2011) Eur. Heart J. , vol.32 , pp. 829-837
    • Otsuka, Y.1
  • 65
    • 0141765805 scopus 로고    scopus 로고
    • Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
    • Moses, J. W. et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med. 349, 1315-1323 (2003).
    • (2003) N. Engl. J. Med. , vol.349 , pp. 1315-1323
    • Moses, J.W.1
  • 66
    • 9144249927 scopus 로고    scopus 로고
    • A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
    • Stone, G. W. et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N. Engl. J. Med. 350, 221-231 (2004).
    • (2004) N. Engl. J. Med. , vol.350 , pp. 221-231
    • Stone, G.W.1
  • 67
    • 33644596656 scopus 로고    scopus 로고
    • Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents
    • Kuchulakanti, P. K. et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am. J. Cardiol. 97, 792-797 (2006).
    • (2006) Am. J. Cardiol. , vol.97 , pp. 792-797
    • Kuchulakanti, P.K.1
  • 68
    • 80054998092 scopus 로고    scopus 로고
    • Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: A report from the linked CathPCI Registry- CMS Claims Database
    • Tsai, T. T. et al. Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: A report from the linked CathPCI Registry- CMS Claims Database. J. Am. Coll. Cardiol. 58, 1859-1869 (2011).
    • (2011) J. Am. Coll. Cardiol. , vol.58 , pp. 1859-1869
    • Tsai, T.T.1
  • 69
    • 33748750070 scopus 로고    scopus 로고
    • Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization
    • Das, P. et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J. Invasive Cardiol. 18, 405-408 (2006).
    • (2006) J. Invasive Cardiol. , vol.18 , pp. 405-408
    • Das, P.1
  • 70
    • 80955158525 scopus 로고    scopus 로고
    • Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry)
    • Green, S. M. et al. Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry). Am. J. Cardiol. 108, 1658-1664 (2011).
    • (2011) Am. J. Cardiol. , vol.108 , pp. 1658-1664
    • Green, S.M.1
  • 71
    • 33846132591 scopus 로고    scopus 로고
    • Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients
    • Halkin, A. et al. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J. Invasive Cardiol. 18, 577-583 (2006).
    • (2006) J. Invasive Cardiol. , vol.18 , pp. 577-583
    • Halkin, A.1
  • 72
    • 68349109552 scopus 로고    scopus 로고
    • Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiency
    • Rosenblum, M. A., Robbins, M. J., Farkouh, M. E., Winston, J. A. & Kim, M. C. Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiency. Nephron Clin. Pract. 113, c198- c202 (2009).
    • (2009) Nephron Clin. Pract. , vol.113
    • Rosenblum, M.A.1    Robbins, M.J.2    Farkouh, M.E.3    Winston, J.A.4    Kim, M.C.5
  • 73
    • 76749142034 scopus 로고    scopus 로고
    • Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency
    • Syed, A. I. et al. Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency. J. Interv. Cardiol. 23, 33-39 (2010).
    • (2010) J. Interv. Cardiol. , vol.23 , pp. 33-39
    • Syed, A.I.1
  • 74
    • 34948830243 scopus 로고    scopus 로고
    • Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients
    • Ishio, I. et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ. J. 71, 1525-1529 (2007).
    • (2007) Circ. J. , vol.71 , pp. 1525-1529
    • Ishio, I.1
  • 75
    • 67650432182 scopus 로고    scopus 로고
    • Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients
    • Yachi, S. et al. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. Am. J. Kidney Dis. 54, 299-306 (2009).
    • (2009) Am. J. Kidney Dis. , vol.54 , pp. 299-306
    • Yachi, S.1
  • 76
    • 39849084996 scopus 로고    scopus 로고
    • Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis
    • Aoyama, T. et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ. J. 72, 56-60 (2008).
    • (2008) Circ. J. , vol.72 , pp. 56-60
    • Aoyama, T.1
  • 77
    • 84862882941 scopus 로고    scopus 로고
    • Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years
    • Simsek, C. et al. Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years. Catheter. Cardiovasc. Interv. 80, 18-26 (2012).
    • (2012) Catheter. Cardiovasc. Interv. , vol.80 , pp. 18-26
    • Simsek, C.1
  • 79
    • 80052296951 scopus 로고    scopus 로고
    • Cardiovascular disease in chronic kidney disease: A clinical update from kidney disease: Improving global outcomes (kdigo)
    • Herzog. et al. Cardiovascular disease in chronic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 80, 572-586 (2011).
    • (2011) Kidney Int. , vol.80 , pp. 572-586
    • Herzog1
  • 80
    • 0034751209 scopus 로고    scopus 로고
    • A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients
    • Stack, A. G. & Bloembergen, W. E. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am. J. Kidney Dis. 38, 992-1000 (2001).
    • (2001) Am. J. Kidney Dis. , vol.38 , pp. 992-1000
    • Stack, A.G.1    Bloembergen, W.E.2
  • 81
    • 0028939185 scopus 로고
    • Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
    • Foley, R. N. et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 47, 186-192 (1995).
    • (1995) Kidney Int. , vol.47 , pp. 186-192
    • Foley, R.N.1
  • 82
    • 0031727746 scopus 로고    scopus 로고
    • Long-term evolution of cardiomyopathy in dialysis patients
    • Foley, R. N. et al. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int. 54, 1720-1725 (1998).
    • (1998) Kidney Int. , vol.54 , pp. 1720-1725
    • Foley, R.N.1
  • 83
    • 77953776647 scopus 로고    scopus 로고
    • Cardiorenal syndrome: New perspectives
    • Bock, J. S. & Gottlieb, S. S. Cardiorenal syndrome: new perspectives. Circulation 121, 2592-2600 (2010).
    • (2010) Circulation , vol.121 , pp. 2592-2600
    • Bock, J.S.1    Gottlieb, S.S.2
  • 84
    • 26044460566 scopus 로고    scopus 로고
    • Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial
    • Binanay, C. et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 294, 1625-1633 (2005).
    • (2005) JAMA , vol.294 , pp. 1625-1633
    • Binanay, C.1
  • 85
    • 38149128221 scopus 로고    scopus 로고
    • Elevated intra-abdominal pressure in acute decompensated heart failure: A potential contributor to worsening renal function?
    • Mullens, W. et al. Elevated intra-abdominal pressure in acute decompensated heart failure: A potential contributor to worsening renal function? J. Am. Coll. Cardiol. 51, 300-306 (2008).
    • (2008) J Am. Coll. Cardiol. , vol.51 , pp. 300-306
    • Mullens, W.1
  • 86
    • 59649118099 scopus 로고    scopus 로고
    • Importance of venous congestion for worsening of renal function in advanced decompensated heart failure
    • Mullens, W. et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J. Am. Coll. Cardiol. 53, 589-596 (2009).
    • (2009) J. Am. Coll. Cardiol. , vol.53 , pp. 589-596
    • Mullens, W.1
  • 87
    • 59649087169 scopus 로고    scopus 로고
    • Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease
    • Damman, K. et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J. Am. Coll. Cardiol. 53, 582-588 (2009).
    • (2009) J. Am. Coll. Cardiol. , vol.53 , pp. 582-588
    • Damman, K.1
  • 88
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomised trial
    • CIBIS-II Investigators and Committees.
    • CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomised trial. Lancet 353, 9-13 (1999).
    • (1999) Lancet , vol.353 , pp. 9-13
  • 89
    • 77953001086 scopus 로고    scopus 로고
    • Improved survival with bisoprolol in patients with heart failure and renal impairment: An analysis of the cardiac insufficiency bisoprolol study II (CIBIS II) trial
    • Castagno, D. et al. Improved survival with bisoprolol in patients with heart failure and renal impairment: An analysis of the cardiac insufficiency bisoprolol study II (CIBIS II) trial. Eur. J. Heart Fail. 12, 607-616 (2010).
    • (2010) Eur. J. Heart Fail. , vol.12 , pp. 607-616
    • Castagno, D.1
  • 90
    • 65349180809 scopus 로고    scopus 로고
    • The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: Insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT HF)
    • Ghali, J. K. et al. The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT HF). J. Card. Fail. 15, 310-318 (2009).
    • (2009) J. Card. Fail. , vol.15 , pp. 310-318
    • Ghali, J.K.1
  • 91
    • 80052365390 scopus 로고    scopus 로고
    • Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis
    • Badve, S. V. et al. Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis. J. Am. Coll. Cardiol. 58, 1152-1161 (2011).
    • (2011) J. Am. Coll. Cardiol. , vol.58 , pp. 1152-1161
    • Badve, S.V.1
  • 92
    • 0035131087 scopus 로고    scopus 로고
    • Dilated cardiomyopathy in dialysis patients-beneficial effects of carvedilol: A double-blind, placebo-controlled trial
    • Cice, G. et al. Dilated cardiomyopathy in dialysis patients - beneficial effects of carvedilol: A double-blind, placebo-controlled trial. J. Am. Coll. Cardiol. 37, 407-411 (2001).
    • (2001) J. Am. Coll. Cardiol. , vol.37 , pp. 407-411
    • Cice, G.1
  • 93
    • 0038408916 scopus 로고    scopus 로고
    • Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial
    • Cice, G. et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial. J. Am. Coll. Cardiol. 41, 1438-1444 (2003).
    • (2003) J. Am. Coll. Cardiol. , vol.41 , pp. 1438-1444
    • Cice, G.1
  • 94
    • 0034642827 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: Is this a cause for concern?
    • Bakris, G. L. & Weir, M. R. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch. Intern. Med. 160, 685-693 (2000).
    • (2000) Arch Intern. Med. , vol.160 , pp. 685-693
    • Bakris, G.L.1    Weir, M.R.2
  • 95
    • 33748949733 scopus 로고    scopus 로고
    • Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies
    • Zannad, F. et al. Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies. Kidney Int. 70, 1318-1324 (2006).
    • (2006) Kidney Int. , vol.70 , pp. 1318-1324
    • Zannad, F.1
  • 96
    • 49749083154 scopus 로고    scopus 로고
    • Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: An open-label randomized controlled trial
    • Suzuki, H. et al. Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: An open-label randomized controlled trial. Am. J. Kidney Dis. 52, 501-506 (2008).
    • (2008) Am. J. Kidney Dis. , vol.52 , pp. 501-506
    • Suzuki, H.1
  • 97
    • 0035818884 scopus 로고    scopus 로고
    • A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    • Cohn, J. N. et al. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 45, 1667-1675 (2001).
    • (2001) N. Engl. J. Med. , vol.45 , pp. 1667-1675
    • Cohn, J.N.1
  • 98
    • 0023266532 scopus 로고
    • Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
    • CONSENSUS Trial Study Group
    • CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N. Engl. J. Med. 31, 1429-1435 (1987).
    • (1987) N. Engl. J. Med. , vol.31 , pp. 1429-1435
  • 99
    • 0026786643 scopus 로고
    • Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction-results of the Survival And Ventricular Enlargement trial
    • Pfeffer, M. A. et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction - results of the Survival And Ventricular Enlargement trial. N. Engl. J. Med. 327, 669-677 (1992).
    • (1992) N. Engl. J. Med. , vol.327 , pp. 669-677
    • Pfeffer, M.A.1
  • 100
    • 0026785561 scopus 로고
    • SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
    • SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N. Engl. J. Med. 327, 685-691 (1992).
    • (1992) N. Engl. J. Med. , vol.327 , pp. 685-691
  • 101
    • 0027423378 scopus 로고
    • Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
    • Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
    • Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342, 821-828 (1993).
    • (1993) Lancet , vol.342 , pp. 821-828
  • 102
    • 0035818884 scopus 로고    scopus 로고
    • A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    • Cohn, J. N. et al. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 345, 1667-1675 (2001).
    • (2001) N. Engl. J. Med. , vol.345 , pp. 1667-1675
    • Cohn, J.N.1
  • 103
    • 0042410539 scopus 로고    scopus 로고
    • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme
    • Pfeffer, M. A. et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme. Lancet 362, 759-766 (2003).
    • (2003) Lancet , vol.362 , pp. 759-766
    • Pfeffer, M.A.1
  • 104
    • 70350228940 scopus 로고    scopus 로고
    • Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure
    • Anand, I. S. et al. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Circulation 120, 1577-1584 (2009).
    • (2009) Circulation , vol.120 , pp. 1577-1584
    • Anand, I.S.1
  • 105
    • 78349252300 scopus 로고    scopus 로고
    • Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure: A double-blind, placebo-controlled trial
    • Cice, G. et al. Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure: A double-blind, placebo-controlled trial. J. Am. Coll. Cardiol. 56, 1701-1708 (2010).
    • (2010) J. Am. Coll. Cardiol. , vol.56 , pp. 1701-1708
    • Cice, G.1
  • 106
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    • Pitt, B. et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341, 709-717 (1999).
    • (1999) N. Engl. J. Med. , vol.341 , pp. 709-717
    • Pitt, B.1
  • 107
    • 0037417252 scopus 로고    scopus 로고
    • Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    • Pitt, B. et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309-1321 (2003).
    • (2003) N. Engl. J. Med. , vol.348 , pp. 1309-1321
    • Pitt, B.1
  • 108
    • 32844467281 scopus 로고    scopus 로고
    • Beneficial impact of spironolactone in diabetic nephropathy
    • Schjoedt, K. J. et al. Beneficial impact of spironolactone in diabetic nephropathy. Kidney Int. 68, 2829-2836 (2005).
    • (2005) Kidney Int. , vol.68 , pp. 2829-2836
    • Schjoedt, K.J.1
  • 109
    • 33845302661 scopus 로고    scopus 로고
    • Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
    • Bianchi, S., Bigazzi, R. & Campese, V. M. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int. 70, 2116-2123 (2006).
    • (2006) Kidney Int. , vol.70 , pp. 2116-2123
    • Bianchi, S.1    Bigazzi, R.2    Campese, V.M.3
  • 110
    • 33746558934 scopus 로고    scopus 로고
    • Double-blind placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker
    • Chrysostomou, A., Pedagogos, E., MacGregor, L. & Becker, G. J. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker. Clin. J. Am. Soc. Nephrol. 1, 256-262 (2006).
    • (2006) Clin. J. Am. Soc. Nephrol. , vol.1 , pp. 256-262
    • Chrysostomou, A.1    Pedagogos, E.2    MacGregor, L.3    Becker, G.J.4
  • 111
    • 38149030811 scopus 로고    scopus 로고
    • Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: A systematic review
    • Bomback, A. S., Kshirsagar, A. V., Amamoo, M. A. & Klemmer, P. J. Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: A systematic review. Am. J. Kidney Dis. 51, 199-211 (2008).
    • (2008) Am. J. Kidney Dis. , vol.51 , pp. 199-211
    • Bomback, A.S.1    Kshirsagar, A.V.2    Amamoo, M.A.3    Klemmer, P.J.4
  • 112
    • 66149131479 scopus 로고    scopus 로고
    • Aldosterone antagonists for preventing the progression of chronic kidney disease: A systematic review and meta-analysis
    • Navaneethan, S. D., Nigwekar, S. U., Sehgal, A. R. & Strippoli, G. F. Aldosterone antagonists for preventing the progression of chronic kidney disease: A systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 4, 542-551 (2009).
    • (2009) Clin. J. Am. Soc. Nephrol. , vol.4 , pp. 542-551
    • Navaneethan, S.D.1    Nigwekar, S.U.2    Sehgal, A.R.3    Strippoli, G.F.4
  • 113
    • 78149424364 scopus 로고    scopus 로고
    • Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease
    • Edwards, N. C. et al. Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease. Am. J. Cardiol. 106, 1505-1511 (2010).
    • (2010) Am. J. Cardiol. , vol.106 , pp. 1505-1511
    • Edwards, N.C.1
  • 114
    • 0242320293 scopus 로고    scopus 로고
    • Safety of low-dose spironolactone administration in chronic haemodialysis patients
    • Saudan, P. et al. Safety of low-dose spironolactone administration in chronic haemodialysis patients. Nephrol. Dial. Transplant. 18, 2359-2363 (2003).
    • (2003) Nephrol. Dial. Transplant. , vol.18 , pp. 2359-2363
    • Saudan, P.1
  • 116
    • 4644313400 scopus 로고    scopus 로고
    • Effect of spironolactone on K+ homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients
    • Michea, L., Vukusich, A., González, M., Zehnder, C. & Marusic, E. T. Effect of spironolactone on K+ homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients. Kidney Int. 66, 1647-1653 (2004).
    • (2004) Kidney Int. , vol.66 , pp. 1647-1653
    • Michea, L.1    Vukusich, A.2    González, M.3    Zehnder, C.4    Marusic, E.T.5
  • 117
    • 63349097399 scopus 로고    scopus 로고
    • Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients
    • Matsumoto, Y. et al. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients. Cardiology 114, 32-38 (2009).
    • (2009) Cardiology , vol.114 , pp. 32-38
    • Matsumoto, Y.1
  • 119
  • 120
    • 33845475422 scopus 로고    scopus 로고
    • A method of determining the dose of digoxin for heart failure in the modern era
    • Bauman, J. L., DiDomenico, R. J., Viana, M. & Fitch, M. A method of determining the dose of digoxin for heart failure in the modern era. Arch. Intern. Med. 166, 2539-2545 (2006).
    • (2006) Arch. Intern. Med. , vol.166 , pp. 2539-2545
    • Bauman, J.L.1    DiDomenico, R.J.2    Viana, M.3    Fitch, M.4
  • 121
    • 33744510817 scopus 로고    scopus 로고
    • Relation of loop diuretic dose to mortality in advanced heart failure
    • Eshaghian, S., Horwich, T. B. & Fonarow, G. C. Relation of loop diuretic dose to mortality in advanced heart failure. Am. J. Cardiol. 97, 1759-1764 (2006).
    • (2006) Am. J. Cardiol. , vol.97 , pp. 1759-1764
    • Eshaghian, S.1    Horwich, T.B.2    Fonarow, G.C.3
  • 122
    • 0033534085 scopus 로고    scopus 로고
    • Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
    • Packer, M. et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 100, 2312-2318 (1999).
    • (1999) Circulation , vol.100 , pp. 2312-2318
    • Packer, M.1
  • 123
    • 0023231642 scopus 로고
    • Aortic and mitral valve calcification in patients with end-stage renal disease
    • Maher, E. R., Young, G., Smyth-Walsh, B., Pugh, S. & Curtis, J. R. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 2, 875-877 (1987).
    • (1987) Lancet , vol.2 , pp. 875-877
    • Maher, E.R.1    Young, G.2    Smyth-Walsh, B.3    Pugh, S.4    Curtis, J.R.5
  • 124
    • 0026550712 scopus 로고
    • Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis
    • Straumann, E. et al. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br. Heart J. 62, 236-239 (1992).
    • (1992) Br. Heart J. , vol.62 , pp. 236-239
    • Straumann, E.1
  • 125
    • 0347906220 scopus 로고    scopus 로고
    • Accelerated progression of calcific aortic stenosis in dialysis patients
    • Perkovic, V. et al. Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin. Pract. 94, c40- c45 (2003).
    • (2003) Nephron Clin. Pract. , vol.94
    • Perkovic, V.1
  • 126
    • 0023232653 scopus 로고
    • Calcific aortic stenosis: A complication of chronic uraemia
    • Maher, E. R., Pazianas, M. & Curtis, J. R. Calcific aortic stenosis: A complication of chronic uraemia. Nephron 47, 119-122 (1987).
    • (1987) Nephron , vol.47 , pp. 119-122
    • Maher, E.R.1    Pazianas, M.2    Curtis, J.R.3
  • 127
    • 33745670164 scopus 로고    scopus 로고
    • Rate of progression of valvular aortic stenosis in patients undergoing dialysis
    • Kume, T. et al. Rate of progression of valvular aortic stenosis in patients undergoing dialysis. J. Am. Soc. Echocardiogr. 19, 914-918 (2006).
    • (2006) J. Am. Soc. Echocardiogr. , vol.19 , pp. 914-918
    • Kume, T.1
  • 128
    • 0037133592 scopus 로고    scopus 로고
    • Long-term survival of dialysis patients in the United States with prosthetic heart valves: Should ACC/AHA practice guidelines on valve selection be modified?
    • Herzog, C A., Ma J. Z. & Collins, A. J. Long-term survival of dialysis patients in the United States with prosthetic heart valves: Should ACC/AHA practice guidelines on valve selection be modified? Circulation 105, 1336-1341 (2002).
    • (2002) Circulation , vol.105 , pp. 1336-1341
    • Herzog, C.A.1    Ma, J.Z.2    Collins, A.J.3
  • 129
    • 55249125191 scopus 로고    scopus 로고
    • 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease
    • a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
    • Bonow, R. O. et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118, e523- e661 (2008).
    • (2008) Circulation , vol.118
    • Bonow, R.O.1
  • 130
    • 0033836213 scopus 로고    scopus 로고
    • Cardiac valve replacement in patients on dialysis: Influence of prosthesis on survival
    • Kaplon, R. J. et al. Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann. Thorac. Surg. 70, 438-441 (2000).
    • (2000) Ann. Thorac. Surg. , vol.70 , pp. 438-441
    • Kaplon, R.J.1
  • 131
    • 0036308859 scopus 로고    scopus 로고
    • Valve replacement in patients on chronic renal dialysis: Implications for valve prosthesis selection
    • Brinkman, W. T., Williams, W. H., Guyton, R. A., Jones, E. L. & Craver, J. M. Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection. Ann. Thorac. Surg. 74, 37-42 (2002).
    • (2002) Ann. Thorac. Surg. , vol.74 , pp. 37-42
    • Brinkman, W.T.1    Williams, W.H.2    Guyton, R.A.3    Jones, E.L.4    Craver, J.M.5
  • 132
    • 32644472467 scopus 로고    scopus 로고
    • Valve replacement surgery in end-stage renal failure: Mechanical prostheses versus bioprostheses
    • Chan, V. et al. Valve replacement surgery in end-stage renal failure: mechanical prostheses versus bioprostheses. Ann. Thorac. Surg. 81, 857-862 (2006).
    • (2006) Ann. Thorac. Surg. , vol.81 , pp. 857-862
    • Chan, V.1
  • 133
    • 82255192469 scopus 로고    scopus 로고
    • Heart valve prosthesis selection in patients with end-stage renal disease requiring dialysis: A systematic review and meta-analysis
    • Chan, V., Chen, L., Mesana, L., Mesana, T. G. & Ruel, M. Heart valve prosthesis selection in patients with end-stage renal disease requiring dialysis: A systematic review and meta-analysis. Heart 97, 2033-2037 (2011).
    • (2011) Heart , vol.97 , pp. 2033-2037
    • Chan, V.1    Chen, L.2    Mesana, L.3    Mesana, T.G.4    Ruel, M.5
  • 134
    • 65249183151 scopus 로고    scopus 로고
    • Dilemmas in the management of atrial fibrillation in chronic kidney disease
    • Reinecke, H. et al. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J. Am. Soc. Nephrol. 20, 705-711 (2009).
    • (2009) J. Am. Soc. Nephrol. , vol.20 , pp. 705-711
    • Reinecke, H.1
  • 135
    • 80655139710 scopus 로고    scopus 로고
    • Warfarin in atrial fibrillation patients with moderate chronic kidney disease
    • Hart, R. G., Pearce, L. A., Asinger, R. W. & Herzog, C. A. Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 2599-2604 (2011).
    • (2011) Clin. J. Am. Soc. Nephrol. , vol.6 , pp. 2599-2604
    • Hart, R.G.1    Pearce, L.A.2    Asinger, R.W.3    Herzog, C.A.4
  • 136
    • 79952316518 scopus 로고    scopus 로고
    • Chronic kidney disease and CHADS2 score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation
    • Nakagawa, K. et al. Chronic kidney disease and CHADS2 score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation. Am. J. Cardiol. 107, 912-916 (2011).
    • (2011) Am. J. Cardiol. , vol.107 , pp. 912-916
    • Nakagawa, K.1
  • 137
    • 84867022051 scopus 로고    scopus 로고
    • Anticoagulants in atrial fibrillation patients with chronic kidney disease
    • Hart, R. G., Eikelboom, J. W., Ingram, A. J. & Herzog, C. A. Anticoagulants in atrial fibrillation patients with chronic kidney disease. Nat. Rev. Nephrol. 8, 569-578 (2012).
    • (2012) Nat. Rev. Nephrol. , vol.8 , pp. 569-578
    • Hart, R.G.1    Eikelboom, J.W.2    Ingram, A.J.3    Herzog, C.A.4
  • 138
    • 0141794137 scopus 로고    scopus 로고
    • Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis
    • Vázquez, E. et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am. J. Cardiol. 92, 868-871 (2003).
    • (2003) Am. J. Cardiol. , vol.92 , pp. 868-871
    • Vázquez, E.1
  • 139
    • 67651124821 scopus 로고    scopus 로고
    • Atrial fibrillation in incident dialysis patients
    • Vázquez, E. et al. Atrial fibrillation in incident dialysis patients. Kidney Int. 76, 324-330 (2009).
    • (2009) Kidney Int. , vol.76 , pp. 324-330
    • Vázquez, E.1
  • 140
    • 65249178935 scopus 로고    scopus 로고
    • Kidney function influences warfarin responsiveness and hemorrhagic complications
    • Limdi, N. A. et al. Kidney function influences warfarin responsiveness and hemorrhagic complications. J. Am. Soc. Nephrol. 20, 912-921 (2009).
    • (2009) J. Am. Soc. Nephrol. , vol.20 , pp. 912-921
    • Limdi, N.A.1
  • 141
    • 78649336758 scopus 로고    scopus 로고
    • Warfarin in haemodialysis patients with atrial fibrillation: What benefit?
    • Yang, F., Chou, D., Schweitzer, P & Hanon, S. Warfarin in haemodialysis patients with atrial fibrillation: what benefit? Europace 12, 1666-1672 (2010).
    • (2010) Europace , vol.12 , pp. 1666-1672
    • Yang, F.1    Chou, D.2    Schweitzer, P.3    Hanon, S.4
  • 142
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly, S. J. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361, 1139-1151 (2009).
    • (2009) N. Engl. J. Med. , vol.361 , pp. 1139-1151
    • Connolly, S.J.1
  • 143
    • 79952301326 scopus 로고    scopus 로고
    • Apixaban in patients with atrial fibrillation
    • Connolly, S. J. et al. Apixaban in patients with atrial fibrillation. N. Engl. J. Med. 364, 806-817 (2011).
    • (2011) N. Engl. J. Med. , vol.364 , pp. 806-817
    • Connolly, S.J.1
  • 144
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • Granger, C. B. et al. Apixaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 365, 981-992 (2011).
    • (2011) N. Engl. J. Med. , vol.365 , pp. 981-992
    • Granger, C.B.1
  • 145
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • Patel, M. R. et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 365, 883-891 (2011).
    • (2011) N. Engl. J. Med. , vol.365 , pp. 883-891
    • Patel, M.R.1
  • 146
    • 79953332012 scopus 로고    scopus 로고
    • Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter
    • Cairns, J. A. et al. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can. J. Cardiol. 27, 74-90 (2011).
    • (2011) Can. J. Cardiol. , vol.27 , pp. 74-90
    • Cairns, J.A.1
  • 147
    • 79956352144 scopus 로고    scopus 로고
    • Sudden cardiac death in hemodialysis patients: An in-depth review
    • Green, D. et al. Sudden cardiac death in hemodialysis patients: An in-depth review. Am. J. Kidney Dis. 57, 921-929 (2011).
    • (2011) Am. J. Kidney Dis. , vol.57 , pp. 921-929
    • Green, D.1
  • 148
    • 26944454055 scopus 로고    scopus 로고
    • Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators
    • Herzog, C. A. et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 68, 818-825 (2005).
    • (2005) Kidney Int. , vol.68 , pp. 818-825
    • Herzog, C.A.1
  • 149
    • 44749094014 scopus 로고    scopus 로고
    • Outcome of patients on renal replacement therapy after colorectal surgery
    • Krysa, J. et al. Outcome of patients on renal replacement therapy after colorectal surgery. Dis. Colon Rectum 51, 961-965 (2008).
    • (2008) Dis. Colon Rectum , vol.51 , pp. 961-965
    • Krysa, J.1
  • 150
    • 0034642322 scopus 로고    scopus 로고
    • Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery
    • Liu, J. Y. et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Circulation 102, 2973-2977 (2000).
    • (2000) Circulation , vol.102 , pp. 2973-2977
    • Liu, J.Y.1
  • 151
    • 34447570985 scopus 로고    scopus 로고
    • Risks of coronary artery bypass surgery in dialysis-dependent patients-analysis of the 2001 National Inpatient Sample
    • Charytan, D. M. & Kuntz, R. E. Risks of coronary artery bypass surgery in dialysis-dependent patients - analysis of the 2001 National Inpatient Sample. Nephrol. Dial. Transplant. 22, 1665-1671 (2007).
    • (2007) Nephrol. Dial. Transplant. , vol.22 , pp. 1665-1671
    • Charytan, D.M.1    Kuntz, R.E.2
  • 152
    • 0032041939 scopus 로고    scopus 로고
    • Prognostic value of dipyridamole thallium 201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation
    • Mistry, B. M. et al. Prognostic value of dipyridamole thallium 201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Clin. Transplant. 12, 130-135 (1998).
    • (1998) Clin. Transplant. , vol.12 , pp. 130-135
    • Mistry, B.M.1
  • 153
    • 0029157691 scopus 로고
    • The evaluation of renal transplant candidates: Clinical practice guidelines Patient care and education committee of the american society of transplant physicians
    • Kasiske, B. L. et al. The evaluation of renal transplant candidates: Clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J. Am. Soc. Nephrol. 6, 1-34 (1995).
    • (1995) J. Am. Soc. Nephrol. , vol.6 , pp. 1-34
    • Kasiske, B.L.1
  • 154
    • 37449014922 scopus 로고    scopus 로고
    • ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery
    • a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery
    • Fleisher, L. A. et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 116, e418- e499 (2007).
    • (2007) Circulation , vol.116
    • Fleisher, L.A.1
  • 155
    • 20144387624 scopus 로고    scopus 로고
    • Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease
    • Wali, R. K. et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J. Am. Coll. Cardiol. 45, 1051-1060 (2005).
    • (2005) J. Am. Coll. Cardiol. , vol.45 , pp. 1051-1060
    • Wali, R.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.